Independent oversight reinforces manufacturing, supply chain integrity, and federal readiness for a platform designed to scale across multiple indications SPRING BRANCH, Texas, March 27, 2026 (GLOBE NEWSWIRE) -- Callan JMB Inc. (NASDAQ: CJMB) (“Callan JMB” or the “Company”), an integrative logistics and operational infrastructure company empowering the healthcare industry and emergency management agencies through fulfillment, storage, monitoring, and cold chain logistics services, today announced its role a ...

Core Insights - Callan JMB Inc. has partnered with Attune Biotech to provide independent oversight for clinical trials of JKB-122 (lodonal), aimed at treating Long COVID, a condition affecting approximately 20 million Americans [1][3][4] Group 1: Company Overview - Callan JMB Inc. is an integrative logistics company that supports the healthcare industry through fulfillment, storage, monitoring, and cold chain logistics services [1][5] - The company has extensive expertise in supply chain logistics, regulatory compliance, and emergency preparedness, positioning it as a leader in the industry [5] Group 2: Partnership Details - The strategic agreement with Attune includes Callan JMB serving as an independent third-party overseer for manufacturing, quality assurance, and deployment operations related to the IND application for JKB-122 [2][4] - Callan JMB will provide services such as CMO qualification, batch record review, supply chain verification, and distribution pathway validation [2] Group 3: Clinical Trial Information - Attune has received FDA notification for IND application number 181314 for JKB-122, which is currently in development for Long COVID [3] - The clinical trial will be a randomized, double-blind, placebo-controlled, multi-center Phase 2b/3 study evaluating the safety and efficacy of JKB-122 in adults with Long COVID [4] Group 4: Product Development - JKB-122 is a first-in-class TLR4 antagonist designed for immune restoration and is being developed for multiple conditions, including Long COVID and autoimmune diseases [4][6] - The product is protected by intellectual property extending through 2041, indicating a long-term development strategy [4][6]

PresentationWayne WilliamsFounder, CEO, President & Chairman Welcome, everybody. I'm glad everybody was able to join. Hopefully, everybody is having a bless day. I'm going to run through the slide deck fairly quick because I really want to focus on questions. It's great to be here again today presenting Callan JMB and everything that we're doing. Some of you have obviously seen the slide deck from previous presentations. There are some minor changes, but we'll -- I'll definitely highlight those pieces. So ...

Core Insights - Callan JMB Inc. has been invited to the 50th International GMP Conference, highlighting its commitment to the healthcare logistics sector [1][2] - The conference serves as a global platform for discussions on regulatory and pharmaceutical industry advancements, co-sponsored by the University of Georgia and the FDA [2] - Wayne Williams, CEO of Callan JMB, emphasizes the importance of staying at the forefront of healthcare logistics amid rapid technological and regulatory changes [3] Company Overview - Callan JMB Inc. is a vertically integrated logistics company focused on empowering the healthcare industry and emergency management through various logistics services [4] - The company specializes in fulfillment, storage, monitoring, and cold chain logistics to ensure the safety and integrity of medical materials [4] - Callan JMB boasts expertise in supply chain logistics, thermodynamics, biologics, inventory management, regulatory compliance, and emergency preparedness [4]

Core Viewpoint - Callan JMB Inc. is actively participating in the iAccess Alpha Virtual Best Ideas Spring Investment Conference, highlighting its role in the healthcare logistics sector [1][2]. Company Overview - Callan JMB Inc. is a vertically integrated logistics company focused on empowering the healthcare industry and emergency management agencies through services such as fulfillment, storage, monitoring, and cold chain logistics [3]. - The company aims to secure medical materials and protect patients and communities by providing compliant, safe, and effective medicines [3]. - Callan JMB boasts expertise in supply chain logistics, thermodynamics, biologics, inventory management, regulatory compliance, and emergency preparedness, positioning itself as a leader in the industry [3]. - The company emphasizes a gold standard in client experience, offering customizable interfaces, reliable shipping, and environmentally sustainable specialty packaging [3].

Core Insights - Callan JMB Inc. is participating in the DealFlow Discovery Conference on January 28-29, 2026, highlighting its role in the healthcare logistics sector [1][2]. Company Overview - Callan JMB Inc. is a vertically integrated logistics company focused on empowering the healthcare industry and emergency management agencies through services such as fulfillment, storage, monitoring, and cold chain logistics [3]. - The company aims to secure medical materials and protect patients and communities by providing compliant, safe, and effective medicines [3]. - Callan JMB boasts expertise in supply chain logistics, thermodynamics, biologics, inventory management, regulatory compliance, and emergency preparedness, positioning itself as a leader in the industry [3]. - The company emphasizes a gold standard in client experience, offering customizable interfaces, reliable shipping, and environmentally sustainable specialty packaging [3].

Core Insights - PainReform Ltd. announced a name change and is expanding into diversified healthcare and AI-driven energy platforms, resulting in a 27.4% increase in share price to $1.02 in pre-market trading [1] Gainers - Acco Group Holdings Limited saw a significant gain of 219.4%, reaching $9.40 in pre-market trading [4] - Venus Concept Inc. increased by 72.2% to $2.48 [4] - Jaguar Health, Inc. rose 41.3% to $1.08 following a licensing agreement with Woodward Specialty [4] - ImmunityBio, Inc. gained 22.8% to $4.85, with preliminary net product revenue for Anktiva projected at approximately $113 million for fiscal 2025, marking a 700% year-over-year increase [4] - OneMedNet Corporation rose 14.2% to $0.9711 after a previous decline [4] - Brand Engagement Network, Inc. increased by 13.8% to $6.50 [4] - Springview Holdings Ltd rose 13.4% to $19.75 after a substantial 657% increase on Thursday [4] - Creative Global Technology Holdings Limited gained 10.7% to $4.22 after a 52% jump on Thursday [4] - Kopin Corporation increased by 8.1% to $3.20 [4] Losers - Callan JMB Inc. fell 20.7% to $3.33 after a 275% increase on Thursday due to a strategic agreement with Biostax Corp [4] - Erayak Power Solution Group Inc. decreased by 18.3% to $3.21 after an 18% rise on Thursday [4] - TryHard Holdings Limited dropped 16.4% to $6.35 following a 76% decline on Thursday due to a joint venture announcement [4] - iOThree Limited shares dipped 15% to $2.56 [4] - NOVONIX Limited fell 14% to $1.17 [4] - Moolec Science SA tumbled 13.1% to $6.69 after an 118% increase on Thursday [4] - High Roller Technologies, Inc. declined 12.9% to $20.64 after a 25% rise on Thursday [4] - Bonk, Inc. fell 10.4% to $3.55 after a 42% increase on Thursday due to acquisition news [4] - J B Hunt Transport Services Inc fell 4.2% to $197.86, reporting mixed financial results for the fourth quarter [4] - QXO Inc dipped 3.5% to $24.14 after announcing a $750 million stock offering and preliminary fourth-quarter net sales of $2.19 billion [4]

分组1 - Callan JMB Inc. (NASDAQ:CJMB) is currently trading at $4.03 with a target price of $2.04, indicating a potential downside of approximately -49.35% [1][5] - PS International Group Ltd. (PSIG) is trading at $4.28, with a discounted cash flow (DCF) valuation of $4.57, resulting in a positive price percentage difference of 6.68% [2][5] - The contrasting market outlook for CJMB and PSIG highlights the challenges faced by CJMB, as its target price is significantly lower than its current market price, while PSIG's DCF valuation exceeds its trading price [3][5] 分组2 - The negative sentiment surrounding CJMB, along with its exclusion from analyst coverage, emphasizes a lack of confidence in the stock's future performance [4] - In contrast, PSIG's positive outlook and potential upside make it a more attractive option for investors seeking growth opportunities in the same industry [4]

Company Highlights - Ambitions Enterprise Management Co. L.L.C (NASDAQ:AHMA) saw its stock price rise to $28.03, marking an 80.88% increase, driven by strong performance in the MICE and tourism sectors [1][7] - authID Inc. (NASDAQ:AUID) experienced a stock price increase to $1.77, a 78.34% rise, reflecting the growing demand for secure, biometric identity verification solutions [2][7] - CALLAN JMB INC. (NASDAQ:CJMB) saw its stock price surge to $3.91, a 249.12% increase, as it shifts towards cold-chain infrastructure to support the $100 billion GLP-1 pharmaceutical market [3][7] - Moolec Science S.A. (NASDAQ:MLEC) experienced a 101.42% increase in its stock price to $7.11, indicating market interest in alternative protein sources and sustainable food technologies [4] - Springview Holdings Ltd (NASDAQ:SPHL) saw its stock price jump to $15.9, a staggering 606.67% increase, highlighting robust demand in the construction sector [5] Industry Trends - The movements in stock prices reflect diverse sectors experiencing growth, including technology, biotechnology, logistics, and construction, indicating broader economic trends and investor interests [6] - Strategic initiatives and partnerships by these companies demonstrate a proactive approach to capitalizing on market opportunities and addressing industry demands [6]

Market Performance - U.S. stocks showed positive movement, with the Nasdaq Composite increasing by approximately 1% on Thursday. The Dow rose by 0.80% to 49,543.16, while the S&P 500 gained 0.74% to 6,977.92 [1] - Information technology shares experienced a gain of 1.5%, while health care stocks saw a decline of 1.5% on the same day [1] Job Market - Initial jobless claims in the U.S. decreased by 9,000 to 198,000 for the week ending January 10, which was better than market expectations of 215,000 [2][10] Commodity Prices - Oil prices fell by 4.7% to $59.08, while gold decreased by 0.4% to $4,618.80. Silver and copper also saw declines of 1.1% to $90.405 and 1.5% to $5.9660, respectively [5] European Market Overview - European shares displayed mixed results, with the eurozone's STOXX 600 rising by 0.39%, while Spain's IBEX 35 Index fell by 0.21%. London's FTSE 100 gained 0.56%, Germany's DAX rose slightly by 0.01%, and France's CAC 40 slipped by 0.23% [6] Asian Market Overview - Asian markets closed lower, with Japan's Nikkei down by 0.42%, Hong Kong's Hang Seng Index declining by 0.28%, and China's Shanghai Composite falling by 0.33% [7] Company News - Callan JMB Inc. shares surged by 208% to $3.45 following a strategic teaming agreement with Biostax Corp [9] - Springview Holdings Ltd saw a significant increase of 290% to $8.96 after announcing a partnership with Jiangsu GSO New Energy Technology Co. for solar solutions in Singapore [9] - authID Inc. shares rose by 99% to $1.98 due to an integration announcement with ServiceNow [9] - MetaVia Inc. shares dropped by 40% to $3.26 after pricing an $8.1 million public offering [9] - Caledonia Mining Corporation PLC shares fell by 19% to $26.39 after announcing a $125 million offering of convertible senior notes [9] - TryHard Holdings Limited shares decreased by 41% to $19.00 following a memorandum of cooperation with STAR PARTY HK LIMITED for a potential joint venture in Japan [9]